Cargando…

LDL cholesterol is associated with higher AD neuropathology burden independent of APOE

OBJECTIVE: APOE is a strong risk factor for Alzheimer’s disease (AD) and associated with higher low-density lipoprotein cholesterol (LDL-C) levels. Moreover, LDL-C is associated with the development of clinically ascertained AD; however, whether this association is present with the underlying neurop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wingo, Aliza P, Vattathil, Selina M, Liu, Jiaqi, Fan, Wen, Cutler, David J, Levey, Allan I, Schneider, Julie A, Bennett, David A, Wingo, Thomas S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Neurodegeneration
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380478/ https://www.ncbi.nlm.nih.gov/pubmed/35772923 http://dx.doi.org/10.1136/jnnp-2021-328164

Ejemplares similares

Neuropathology and emerging biomarkers in corticobasal syndrome
por: Koga, Shunsuke, et al.
Publicado: (2022)

Fine particulate air pollution and neuropathology markers of Alzheimer’s disease in donors with and without APOE ε4 alleles – results from an autopsy cohort
por: Christensen, Grace M., et al.
Publicado: (2023)

Shared mechanisms across the major psychiatric and neurodegenerative diseases
por: Wingo, Thomas S., et al.
Publicado: (2022)

Sex differences in brain protein expression and disease
por: Wingo, Aliza P., et al.
Publicado: (2023)

Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis
por: Thompson, Alexander G, et al.
Publicado: (2022)

A Genetic Study of Cerebral Atherosclerosis Reveals Novel Associations with NTNG1 and CNOT3
por: Vattathil, Selina M., et al.
Publicado: (2021)

Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition
por: Rauchmann, Boris Stephan, et al.
Publicado: (2021)

Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia
por: Graham, Neil SN, et al.
Publicado: (2019)

Examining the language and behavioural profile in FTD and ALS-FTD
por: Saxon, Jennifer A, et al.
Publicado: (2017)

Longitudinal changes of spinal cord grey and white matter following spinal cord injury
por: David, Gergely, et al.
Publicado: (2021)

Differential DNA Methylation in the Brain as Potential Mediator of the Association between Traffic-related PM(2.5) and Neuropathology Markers of Alzheimer’s Disease
por: Li, Zhenjiang, et al.
Publicado: (2023)

Pure tone audiometry and cerebral pathology in healthy older adults
por: Parker, Thomas, et al.
Publicado: (2020)

Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis
por: David, Michael C B, et al.
Publicado: (2022)

Neurite orientation and dispersion density imaging (NODDI) detects cortical and corticospinal tract degeneration in ALS
por: Broad, Rebecca J, et al.
Publicado: (2019)

Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis
por: Kmetzsch, Virgilio, et al.
Publicado: (2021)

Subjective cognitive complaints at age 70: associations with amyloid and mental health
por: Pavisic, Ivanna M., et al.
Publicado: (2021)

Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia
por: van der Ende, Emma L, et al.
Publicado: (2020)

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
por: Meeter, Lieke H H, et al.
Publicado: (2019)

Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?
por: Kanouchi, Tadashi, et al.
Publicado: (2012)

Medial temporal lobe epilepsy is associated with neuronal fibre loss and paradoxical increase in structural connectivity of limbic structures
por: Bonilha, Leonardo, et al.
Publicado: (2012)

Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans
por: Maccecchini, Maria L, et al.
Publicado: (2012)

An algorithmic approach to structural imaging in dementia
por: Harper, Lorna, et al.
Publicado: (2014)

Validation of the new consensus criteria for the diagnosis of corticobasal degeneration
por: Alexander, S K, et al.
Publicado: (2014)

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
por: Magdalinou, Nadia, et al.
Publicado: (2014)

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
por: Berge, Guro, et al.
Publicado: (2014)

The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey
por: Turner, Martin R, et al.
Publicado: (2015)

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study
por: Lu, Ching-Hua, et al.
Publicado: (2015)

Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2016)

Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records
por: Evans, Stephen JW, et al.
Publicado: (2013)

Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights
por: Vucic, Steve, et al.
Publicado: (2013)

Doxycycline in early CJD: a double-blinded randomised phase II and observational study
por: Varges, Daniela, et al.
Publicado: (2017)

ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
por: Wang, Jinping, et al.
Publicado: (2016)

Quantitative EEG parameters correlate with the progression of human prion diseases
por: Franko, Edit, et al.
Publicado: (2016)

Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial
por: Charlesworth, Georgina, et al.
Publicado: (2016)

Neuronal network disintegration: common pathways linking neurodegenerative diseases
por: Ahmed, Rebekah M, et al.
Publicado: (2016)

A clinical tool for predicting survival in ALS
por: Knibb, Jonathan A, et al.
Publicado: (2016)

Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion
por: Westeneng, Henk-Jan, et al.
Publicado: (2016)

Flavour identification in frontotemporal lobar degeneration
por: Omar, Rohani, et al.
Publicado: (2013)

Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis
por: Harper, Lorna, et al.
Publicado: (2017)

Genetic screening in sporadic ALS and FTD
por: Turner, Martin R, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c9ald0rfd91ve1v3ns2e0a4cak